BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8846510)

  • 1. Opioid mechanisms controlling renal function.
    Kapusta DR
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):891-902. PubMed ID: 8846510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
    Kapusta DR; Obih JC
    J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central mu opioid receptor-mediated changes in renal function in conscious rats.
    Kapusta DR; Obih JC; Dibona GF
    J Pharmacol Exp Ther; 1993 Apr; 265(1):134-43. PubMed ID: 8097241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth.
    Hatzoglou A; Bakogeorgou E; Papakonstanti E; Stournaras C; Emmanouel DS; Castanas E
    J Cell Biochem; 1996 Dec; 63(4):410-21. PubMed ID: 8978457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
    Kapusta DR; Jones SY; DiBona GF
    J Pharmacol Exp Ther; 1991 Jul; 258(1):111-7. PubMed ID: 1677034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calcium currents in rat colon sensory neurons by K- but not mu- or delta-opioids.
    Su X; Wachtel RE; Gebhart GF
    J Neurophysiol; 1998 Dec; 80(6):3112-9. PubMed ID: 9862909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine.
    Shahbazian A; Heinemann A; Schmidhammer H; Beubler E; Holzer-Petsche U; Holzer P
    Br J Pharmacol; 2002 Feb; 135(3):741-50. PubMed ID: 11834622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects.
    Dykstra LA; Preston KL; Bigelow GE
    Psychopharmacology (Berl); 1997 Mar; 130(1):14-27. PubMed ID: 9089845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
    Stevens CW; Rothe KS
    Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ).
    Kapusta DR; Sezen SF; Chang JK; Lippton H; Kenigs VA
    Life Sci; 1997; 60(1):PL15-21. PubMed ID: 8995537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro.
    Chieng B; Christie MJ
    Br J Pharmacol; 1994 Sep; 113(1):121-8. PubMed ID: 7812601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mu and kappa opioid systems modulate responses to cutaneous perioral stimulation in the fetal rat.
    Smotherman WP; Simonik DK; Andersen SL; Robinson SR
    Physiol Behav; 1993 Apr; 53(4):751-6. PubMed ID: 8390058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa opioids exert a strong antiproliferative effect on PC12 rat pheochromocytoma cells.
    Venihaki M; Gravanis A; Margioris AN
    Peptides; 1996; 17(3):413-9. PubMed ID: 8735967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats.
    Cabral AM; Varner KJ; Kapusta DR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):609-16. PubMed ID: 9262322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic potency of mu and kappa opioids after systemic administration in amphibians.
    Stevens CW; Klopp AJ; Facello JA
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1086-93. PubMed ID: 8014851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu- and kappa-opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin.
    Barber A
    Eur J Pharmacol; 1993 May; 236(1):113-20. PubMed ID: 8391450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.